Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Murali Prahalad, Stephen Chanock

Premium

Epic Sciences has appointed Murali Prahalad as President and CEO. Prahalad joins Epic from Life Technologies where he was vice president of corporate strategy and helped shape investment priorities in research tools, clinical diagnostics, and applied markets.


The National Cancer Institute has appointed Stephen Chanock to be director of NCI’s Division of Cancer Epidemiology and Genetics and a scientific director of the institute.

Chanock takes over DCEG from founding Director Joseph Fraumeni, who stepped down from the post a year ago.

Chanock formerly was a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in NCI’s Center for Cancer Research, he was co-chair of NCI’s Genetics, Genomics, and Proteomics Faculty, and he was chief of the Cancer Genomics Research Laboratory and the Laboratory of Translational Genomics. He also was acting director of the NCI Center for Cancer Genomics from 2012 to 2013.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.